January 2024
1. WEBER JS, Carlino MS, Khattak A, Meniawy T, et al
   Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study.
   Lancet. 2024 Jan 18:S0140-6736(23)02268-7. doi: 10.1016/S0140-6736(23)02268.
   

   >> Share

   
   July 2023
2. LONG GV, Swetter SM, Menzies AM, Gershenwald JE, et al
   Cutaneous melanoma.
   Lancet. 2023 Jul 24:S0140-6736(23)00821-8. doi: 10.1016/S0140-6736(23)00821.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share